In Depth 17 Dec 2024 Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic Cancer vaccines are a kind of immunotherapy that are meant to recognize cancer cells in the body and destroy them. But what if they could prevent the spread of cancer… December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 …to evaluate a lead-212-based candidate to treat neuroendocrine tumors and small cell lung cancers. Cancers such as small cell lung cancer are highly aggressive and can quickly become treatment resistant…. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Biotech conferences and events 2022-2023 …Taipei, Taiwan Europe 4-5 AFSSI Connexions, Montpellier, France 12-13 Global Summit on Breast and Women’s Cancer, Paris, France 18-21 Animal Models of Cancer Conference, Lisbon, Portugal Americas 20-22 NRG Meeting,… December 13, 2023 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Biotech conferences and events …UK 9-11 5th European CAR T-cell Meeting, Rotterdam, The Netherlands 15-17 21st International AEK Cancer Congress, Kassel, Germany 23-24 ESMO Gynaecological Cancers Annual Congress, Barcelona, Spain 25 Edinburgh Breast Cancer… September 1, 2022 - 2 minutesmins - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
2024 biotech deals tracker: the latest partnerships and M&A …CDK inhibitors for an upfront payment of $850 million. The assets being acquired include CDK inhibitors for breast cancer. December 2024: COUR Pharmaceuticals, based in the United States, is partnering… March 7, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 8 Apr 2019 AACR 2019: European Biotech Progresses in Fighting Cancer …promise for other forms of cancer, including treating breast cancer and as a combination of the radiotherapy enhancer and a checkpoint inhibitor for lung cancer. The UK biotech MiNA Therapeutics… April 8, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 23 Jul 2024 First AKT-targeting drug capivasertib to hit the market, could it open the door for more? …AKT inhibitor targets the PI3K/AKT/mTOR signaling pathway, which is often dysregulated in various cancers, including breast cancer. This approval might not only be a win for AstraZeneca and Astex but… July 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 15 Mar 2023 10 immunotherapy companies making waves in 2023 …the treatment of certain melanomas, breast cancer and colorectal cancer, the company has collaborated with Moffitt Cancer Center and National Cancer Institute to develop TIDAL-01, a therapy in phase one… March 15, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 12 Feb 2020 Boosting Cancer Research by Unlocking Genomic Data …data of these CROs’ preclinical cancer models, processes it, and standardizes it within its database. “A researcher who is currently testing a cancer drug and is looking for a cancer… February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
More News! 28 Oct 2022 ‘Dark matter’ creates a whole new level of cancer gene activity in tumors, researchers say …dark matter’ Professor Trevor Graham, director of the center for evolution and cancer at the Institute of Cancer Research, said: “We’ve unveiled an extra level of control for how cancers… October 28, 2022 - 6 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 29 Jan 2025 Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic …pelareorep for pancreatic cancer Canadian company Oncolytics Biotech is developing a drug called pelareorep, which has shown promise in a number of cancer types, particularly breast and pancreatic cancer. Pelareorep… January 29, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by B2B - Breast2Bone 21 Feb 2023 From breast to bone: Refining metastasis drug discovery with a novel organ-on-a-chip device …human model. Organ-on-a-chip B2B device The setup of the B2B device enables circulating tumor cell migration from breast to bone tissue Meet the Breast to Bone multi-chamber device The Breast… February 21, 2023 - 6 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email